IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): CAR PEPTIDE THERAPEUTIC ADJUVANT FOR PAH TARGETED THERAPY

Information

• Research Project
• 8947669

• ApplicationId

  8947669

• Core Project Number

  N01HB000000

• Full Project Number

  268201400006C-0-0-1

• Serial Number

• FOA Number

• Sub Project Id

• Project Start Date

  11/15/2013 - 10 years ago

• Project End Date

  11/14/2014 - 9 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2014

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• VASCULAR BIOSCIENCES, INC.

The Vascular Interventions/Innovations and Therapeutic Advances (VITA) Program is a new translational initiative of the National Heart, Lung, and Blood Institute (NHLBI) that enables and accelerates the development of promising diagnostic and therapeutic modalities for unmet and underserved medical needs. The VITA Program provides contract support for early-stage translational development of product candidates in the fields of vascular disorders, thrombotic diseases, and pulmonary hypertension.

IC Name

• Activity

  N01

• Administering IC

  HL

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  361958

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  837

• Ed Inst. Type

• Funding ICs

  NHLBI:361958\

• Funding Mechanism

  Non SBIR/STTR Contracts

• Study Section

• Study Section Name

• Organization Name

  VASCULAR BIOSCIENCES

• Organization Department

• Organization DUNS

  112025965

• Organization City

  SAN DIEGO

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  921092646

• Organization District

  UNITED STATES